January 23, 2019
FTC and umbilical cord-derived stem cells

FTC Sets the Clinical Study Standards for Advertising Health-related Claims – Part One

The recent FTC actions against a physician who practiced miraculous regenerative medicine suggest a tightening of the allowed actions and activities of the field with respect to making claims and advertising, which clinics use to differentiate themselves from the group down the street. However, the recent FTC court action shows the perils going forward of...
Read More